NASDAQ · BON

Bon Natural Life Limited financials

$1.20−1.64%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Sep 30
FY24
Sep 30
FY23
Sep 30
FY22
Sep 30
FY21
Sep 30
Revenue$18.7M$23.8M$29.5M$29.9M$25.5M
Gross profit$3.9M$7.1M$8.8M$9.4M$7.1M
Gross margin20.8%29.8%29.9%31.5%27.9%
Operating income-$1.6M$1.9M$5.9M$6.6M$5.4M
Net income-$2.0M$398.2K$4.6M$6.2M$4.6M
Net margin−10.7%1.7%15.6%20.9%18.0%
Diluted EPS$-0.72$4.14$124.92$185.75$17.00
EBITDA-$535.6K$3.0M$6.9M$6.8M$5.6M
Operating cash flow$141.1K-$7.7M-$616.9K-$187.1K$4.1M
Free cash flow-$4.2M-$7.7M-$678.8K-$2.3M-$431.7K
Diluted shares2.8M0.1M0.0M0.0M0.3M

Balance sheet

Period endSep 30Sep 30Sep 30Sep 30Sep 30
Cash & equivalents$3.8M$80.5K$111.3K$840.9K$1.9M
Short-term investments$0.00$0.00$0.00$0.00$1.7M
Total debt$12.2M$7.2M$3.8M$4.8M$2.9M
Total assets$85.2M$61.8M$46.6M$37.3M$36.4M
Total liabilities$27.2M$17.4M$10.6M$7.2M$9.9M
Shareholders' equity$58.0M$44.3M$36.0M$30.1M$26.5M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology